라벨 머무름 확장 현미경(LR-ExM)으로 초고해상도 이미징 및 고효율 라벨링 가능

Executive Industry Relevance

Label-retention expansion microscopy (LR-ExM) addresses a critical bottleneck in super-resolution imaging by preserving fluorescence signal and maximizing labeling efficiency during sample expansion. This enables robust visualization of cellular and subcellular structures at nanometric resolution, supporting high-confidence target validation and mechanistic de-risking in early discovery. LR-ExM's compatibility with immunofluorescence and self-labeling tags positions it as a versatile platform for scalable, quantitative imaging across diverse R&D pipelines.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Enables high-resolution interrogation of molecular targets and cellular architecture.
• Supports functional target validation by preserving signal during expansion and imaging.
• Facilitates mechanistic de-risking through precise visualization of protein complexes and organelles.
• Improves predictive confidence in early-stage biological hypotheses.

Screening & Assay Development

• Provides standardized, reproducible sample preparation for quantitative imaging assays.
• Enhances assay sensitivity and dynamic range by minimizing fluorescence loss.
• Enables robust detection of small or low-abundance structures for screening readiness.
• Supports platform reuse with compatibility across immunostaining and self-labeling workflows.

Translational & Preclinical Research

• Aligns imaging outputs with disease-relevant biomarkers in tissue and cell models.
• Maintains continuity from discovery through preclinical validation by supporting multiplexed labeling.
• Reduces translational risk by enabling high-efficiency, quantitative imaging in complex samples.
• Supports risk-adjusted advancement decisions with reliable structural data.

Pipeline & Workflow Integration

LR-ExM integrates into the discovery-to-preclinical continuum by enabling high-resolution, quantitative imaging for target validation, assay development, and translational research.

• Discovery Biology: Facilitates hypothesis testing and pathway clarification by preserving molecular detail during expansion.
• Screening: Delivers reproducible, quantitative fluorescence outputs for comparative analysis across conditions.
• Analytics: Provides robust signal-to-noise ratios and multiplexed readouts for statistical evaluation.
• Translational Research: Supports biomarker alignment and disease-relevant imaging in tissue samples.
• Enterprise Reuse: Offers a versatile, adaptable imaging platform for diverse R&D applications.

Operational & Enterprise Impact

• Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in target validation.
• Operational Value: Standardizes imaging workflows and enhances reproducibility across teams.
• Strategic Value: Improves go/no-go decision quality and capital efficiency by providing high-content data early.
• Portfolio Impact: Enables risk-adjusted prioritization and advancement of discovery programs.

Implementation Considerations

• Requires expertise in advanced fluorescence microscopy and sample preparation.
• Needs access to compatible imaging platforms and analytical infrastructure.
• Demands cross-team standardization of labeling and expansion protocols.
• Adaptable to both cell culture and tissue models with protocol optimization.
• Dependent on effective use of trifunctional anchors for maximal signal retention.

Biopharma FAQs